Anthrax Protective Antigen Retargeted with Single‐Chain Variable Fragments Delivers Enzymes to Pancreatic Cancer Cells
The nontoxic, anthrax protective antigen/lethal factor N-terminal domain (PA/LFN ) complex is an effective platform for translocating proteins into the cytosol of cells. Mutant PA (mPA) was recently fused to epidermal growth factor (EGF) to retarget delivery of LFN to cells bearing EGF receptors (EG...
Main Authors: | Loftis, Alexander Robert, Santos, Michael, Truex, Nicholas, Biancucci, Marco, Satchell, Karla J. F., Pentelute, Bradley L. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Language: | English |
Published: |
Wiley
2020
|
Online Access: | https://hdl.handle.net/1721.1/128117 |
Similar Items
-
Targeting cancer gene dependencies with anthrax-mediated delivery of peptide nucleic acids
by: Lu, Zeyu, et al.
Published: (2021) -
Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids
by: Lu, Zeyu, et al.
Published: (2022) -
Substrate Recognition of MARTX Ras/Rap1-Specific Endopeptidase
by: Biancucci, Marco, et al.
Published: (2018) -
Delivery of Antibody Mimics into Mammalian Cells via Anthrax Toxin Protective Antigen
by: Liao, Xiaoli, et al.
Published: (2014) -
Atomic structure of anthrax protective antigen pore elucidates toxin translocation
by: Jiang, Jiansen, et al.
Published: (2017)